Keefe, Bruyette & Woods Maintains Federal Home Loan Mortgage Corporation - Preferred Stock (FMCKI) Underperform Recommendation

Keefe, Bruyette & Woods maintained an Underperform rating on Federal Home Loan Mortgage Corporation - Preferred Stock (OTCPK:FMCKI) while the average one-year analyst price target sits at $15.16 (range $2.37–$30.80), implying a 345.85% upside from the last close of $3.40. Company projections show annual revenue of $13,310MM, down 40.86%, with projected non-GAAP EPS of 6.00; institutional ownership is limited (one fund, 180K shares) and unchanged quarter-over-quarter. The note presents conflicting signals—an official underperform stance and weak fundamentals versus a high consensus price target—leaving actionable conviction low for large reallocations.

Analysis

Market structure: FMCKI (OTCPK:FMCKI) is an illiquid GSE-preferred instrument where winners are holders of higher-quality agency paper (e.g., MBB, FMCC common) and arbitrageurs able to absorb >180k-share moves; losers are retail/benchmarked funds facing mark-to-market losses because only one institutional holder (Pinnacle) suggests a tiny float and high price impact. Competitive dynamics hinge on FHFA/GSE policy and buyback/treatment of preferreds — any explicit capital relief or dividend resumption would reprice FMCKI sharply higher; absent that, spreads versus on-the-run agency debt will widen, compressing pricing power for holders. Supply/demand: reported projected revenue decline (~40%) and static institutional positioning implies supply (forced sellers) may exceed willing buyers at current levels, increasing downside risk until a liquidity-creating catalyst appears. Cross-asset: a disorderly move in FMCKI would be concentrated to OTC preferreds and agency MBS spreads (MBB), with limited direct FX/commodity impact but potential basis moves in short-term repo and Treasury bills as dealers adjust balance sheets.

Risk assessment: Tail risks include FHFA regulatory action (e.g., forced writedown or conversion) and a sudden liquidity withdrawal causing a 50–90% gap down within days; operational risk from borrow recalls could amplify losses. Time horizons: immediate (days) — headline-driven spikes; short-term (weeks–months) — repositioning around FHFA statements, quarterly reports; long-term (quarters–years) — housing cycle and capital treatment determine recovery to analyst targets. Hidden dependencies: funding conditions (repo/GC), mortgage prepayment speeds, and any negotiated GSE capital settlements are second-order drivers. Catalysts to watch (30–90 days): FHFA releases, Treasury/GSE negotiations, and any unconventional analyst-driven block trades that shift visible holders above 1% institutional ownership.

Key Decisions for Investors

• Avoid initiating >1% NAV directional exposure to FMCKI (OTCPK:FMCKI). If holding, reduce to zero or hedge within 30 days given KBW Underperform and extreme analyst dispersion; set tactical hard stop at $1.50 (approx. -56%) and cap upside target at $15.16 within 12 months only if FHFA signals capital relief.
• Establish a small opportunistic long (0.25–0.5% NAV) in FMCKI only on a confirmed liquidity event: entry < $3.00, hard stop $1.50, scale to 1% NAV only if institutional holdings rise >50% or weekly volume >500% of average; target 6–12 month hold to $8–$15 contingent on policy catalysts.
• Relative-value pair: long iShares MBS ETF (MBB) 1–2% NAV and short FMCKI 0.5% NAV to capture expected spread compression if market re-rates agency credit; unwind if MBB/FMCKI spread tightens <200 bps or FMCKI trades above $8 for two consecutive weeks.
• Options/hedge: if borrow cost <3% pursue a 3-month synthetic short via buying puts on FMCKI (if available) or buying puts on MBB as proxy protection; alternatively use non-deliverable forward/OTC equity swaps with counterparty haircut triggers and close if borrow recalled or price moves >40% intraday.